12:00 AM
Jan 07, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

once-monthly Actonel/Benet risedronate regulatory update

On Dec. 25, 2012, Ajinomoto Pharmaceuticals Co. Ltd. (Tokyo, Japan) and Takeda said Japan's Ministry of Health, Labor and Welfare (MHLW) approved once-monthly Actonel/Benet...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >